(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

INIBIDORES DE CTPS1 PARA USO NO TRATAMENTO DE CÂNCER COM DEFICIÊNCIA DE CTPS2

Em AnáliseInvention PatentPCT · EP2023087338
Talk to an expert

Application data

Number

112025009220

Type

Invention Patent

Filing

12/21/2023

Publication

12/23/2025

PCT

EP2023087338
View on INPI

Progress at the INPI

Examination not yet requested
  1. Filing12/21/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 12/21/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:12/21/2026(118 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 12/23/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

STEP PHARMA S.A.S.

FR

Inventors

A. P. (pessoa física)

FR

P. B. (pessoa física)

FR

Technical data

IPC Classification

A61K 31/506A61P 35/00

Priority claims

EP

22306966.7 · 12/21/2022

Abstract

INIBIDORES DE CTPS1 PARA USO NO TRATAMENTO DE CÂN CER COM DEFICIÊNCIA DE CTPS2. A presente invenção refere-se a, entre outros, métodos de tratamento de cânceres com deficiência de CTPS2 por meio da administração de inibidores de CTPS1 e aspectos relacionados.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

12/23/2025

RPI 2868

Alteração de dados cadastrais

#1.1

06/10/2025

RPI 2840

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.